1 The primary outcome
was the proportion of adolescents who had died or had a viral
2 The main outcome
was the proportion of agreement between the ICD code and the
3 y composite efficacy endpoint (intention-to-treat analysis)
was the proportion of children with complete thrombus resolut
4 Primary endpoint
was the proportion of cycles with uCrCl < 50 ml/min/1.73m(2)
5 The primary endpoint
was the proportion of DTG-arm participants with plasma HIV-1-
6 The primary outcome
was the proportion of episodes with out-of-network bills.
7 The primary end point
was the proportion of eyes with a clinically meaningful impro
8 The main outcome
was the proportion of facility patients vaccinated for influe
9 The primary endpoint
was the proportion of false-negative patients with tumor regr
10 The primary outcome
was the proportion of fertile and viable female worms in onch
11 The primary outcome
was the proportion of individuals with germline PVs (LS PVs,
12 The primary outcome
was the proportion of infants with a successful first attempt
13 The primary outcome
was the proportion of men having a repeated PSA test within 2
14 The primary end point
was the proportion of men with at least one responding bone l
15 The primary outcome
was the proportion of outpatients tested for HIV on the day o
16 The safety endpoint
was the proportion of participants developing adverse reactio
17 The primary endpoint
was the proportion of participants discontinuing due to adver
18 The primary outcome
was the proportion of participants followed 1 year without re
19 The primary efficacy endpoint
was the proportion of participants who had a plasma HIV-1 RNA
20 Our primary outcome
was the proportion of participants who maintained ART through
21 The primary endpoint
was the proportion of participants who were microfilaria (Mf)
22 The primary endpoint
was the proportion of participants with clearance of S sterco
23 The primary endpoint
was the proportion of patients achieving a 50% or higher impr
24 The primary endpoint
was the proportion of patients achieving a brain metastasis r
25 The primary end point
was the proportion of patients achieving a complete response
26 of venetoclax plus chemotherapy and the secondary endpoint
was the proportion of patients treated at the recommended pha
27 The primary endpoint
was the proportion of patients virologically suppressed with
28 The primary endpoint
was the proportion of patients who achieved an objective resp
29 The primary endpoint
was the proportion of patients who could first de-escalate th
30 The primary outcome
was the proportion of patients who demonstrated IOP of <21 mm
31 The key secondary endpoint
was the proportion of patients with >=7% weight gain.
32 The primary efficacy endpoint
was the proportion of patients with <50 HIV-1 RNA copies/mL o
33 The primary outcome
was the proportion of patients with 1 or more flares (worseni
34 The primary outcome
was the proportion of patients with a reduction of 50% or mor
35 The primary endpoint
was the proportion of patients with an objective response (ce
36 The primary endpoint
was the proportion of patients with an objective response (co
37 The primary outcome
was the proportion of patients with an overall response (comp
38 The primary outcome
was the proportion of patients with at least 20% improvement
39 The primary endpoint
was the proportion of patients with at least 50% improvement
40 The primary endpoint
was the proportion of patients with at least a 50% reduction
41 The primary efficacy endpoint
was the proportion of patients with confirmed undetectable pl
42 The primary endpoint
was the proportion of patients with less than 50 HIV-1 RNA co
43 The primary outcome
was the proportion of patients with macula-on RRD at presenta
44 The primary end point
was the proportion of patients with sufficient improvement of
45 The primary endpoint
was the proportion of patients with sustained-virological res
46 The primary endpoint
was the proportion of patients with undetectable plasma viral
47 The primary outcome
was the proportion of polymerase chain reaction (PCR)-adjuste
48 The primary outcome
was the proportion of randomly assigned patients in the inten
49 The primary efficacy endpoint
was the proportion of subjects with an AC cell count of zero
50 The primary outcome
was the proportion of subjects with therapeutic (clinical and